Valeant (VRX) Puts Inova Unit Up for Sale - Report

September 21, 2016 10:16 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

(Updated - September 21, 2016 10:25 AM EDT)

Valeant Pharmaceuticals (NYSE: VRX) has put its Australian Inova unit up for sale, AFR reported.

The company has tapped Goldman Sachs as its banker, the report said.

AFR said Inova has EBITDA of roughly $100 million annually. The unit could be worth $1 billion in a sale.


Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors

Related Entities

Goldman Sachs

Add Your Comment